Phase 1 study of tazemetostat, an enhancer of zeste homolog-2 (EZH2) inhibitor, in pediatric patients with relapsed/refractory integrase interactor 1 (INI1)-negative tumors Meeting Abstract
| Authors: | Chi, S.; Bourdeaut, F.; Laetsch, T.; Fouladi, M.; Macy, M.; Makin, G.; Shukla, N.; Wetmore, C.; Margol, A.; Casanova, M.; Kilburn, L.; Yi, J.; Hargrave, D.; McCowage, G.; Pinto, N.; Ebb, D.; Robinson, G.; Sierra, L.; Merchant, M.; Nysom, K. |
| Abstract Title: | Phase 1 study of tazemetostat, an enhancer of zeste homolog-2 (EZH2) inhibitor, in pediatric patients with relapsed/refractory integrase interactor 1 (INI1)-negative tumors |
| Meeting Title: | 52nd Congress of the International Society of Paediatric Oncology (SIOP) |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 67 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Oct 14-17 |
| Meeting Location: | Virtual |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2020-12-01 |
| Start Page: | S123 |
| End Page: | S124 |
| Language: | English |
| ACCESSION: | WOS:000581769200257 |
| PROVIDER: | wos |
| PUBMED: | 33049088 |
| DOI: | 10.1002/pbc.28742 |
| Notes: | Meeting Abstract: 0261 / #476 -- Source: Wos |
